Form 8-K - Current report:
SEC Accession No. 0001493152-26-010526
Filing Date
2026-03-17
Accepted
2026-03-17 16:00:33
Documents
13
Period of Report
2026-03-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 48540
2 EX-10.1 ex10-1.htm EX-10.1 16986
3 EX-99.1 ex99-1.htm EX-99.1 15689
  Complete submission text file 0001493152-26-010526.txt   260478

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mgrx-20260316.xsd EX-101.SCH 3032
5 XBRL LABEL FILE mgrx-20260316_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE mgrx-20260316_pre.xml EX-101.PRE 22370
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3376
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 26761615
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)